DNLI
Price
$15.27
Change
-$0.38 (-2.43%)
Updated
Aug 29 closing price
Capitalization
2.23B
58 days until earnings call
HLVX
Price
$2.09
Change
+$0.01 (+0.48%)
Updated
Aug 29 closing price
Capitalization
104.76M
66 days until earnings call
Interact to see
Advertisement

DNLI vs HLVX

Header iconDNLI vs HLVX Comparison
Open Charts DNLI vs HLVXBanner chart's image
Denali Therapeutics
Price$15.27
Change-$0.38 (-2.43%)
Volume$1.89M
Capitalization2.23B
HilleVax
Price$2.09
Change+$0.01 (+0.48%)
Volume$169.27K
Capitalization104.76M
DNLI vs HLVX Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. HLVX commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a StrongBuy and HLVX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (DNLI: $15.27 vs. HLVX: $2.09)
Brand notoriety: DNLI and HLVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 114% vs. HLVX: 26%
Market capitalization -- DNLI: $2.23B vs. HLVX: $104.76M
DNLI [@Biotechnology] is valued at $2.23B. HLVX’s [@Biotechnology] market capitalization is $104.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileHLVX’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • HLVX’s FA Score: 1 green, 4 red.
According to our system of comparison, HLVX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while HLVX’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 4 bearish.
  • HLVX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, HLVX is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -1.42% price change this week, while HLVX (@Biotechnology) price change was +1.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.59%, and the average quarterly price growth was +30.71%.

Reported Earning Dates

DNLI is expected to report earnings on Oct 30, 2025.

HLVX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.23B) has a higher market cap than HLVX($105M). HLVX YTD gains are higher at: 0.966 vs. DNLI (-25.074). HLVX has higher annual earnings (EBITDA): -66.58M vs. DNLI (-521.52M). DNLI has more cash in the bank: 899M vs. HLVX (160M). HLVX has less debt than DNLI: HLVX (23.5M) vs DNLI (46.6M). DNLI (0) and HLVX (0) have equivalent revenues.
DNLIHLVXDNLI / HLVX
Capitalization2.23B105M2,127%
EBITDA-521.52M-66.58M783%
Gain YTD-25.0740.966-2,595%
P/E RatioN/AN/A-
Revenue00-
Total Cash899M160M562%
Total Debt46.6M23.5M198%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIHLVX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
80%
Bearish Trend 6 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAYMF0.340.04
+12.27%
Galway Metals Inc.
PHPRF1.260.01
+0.80%
Primary Health Properties Plc.
ABNAF0.05N/A
N/A
Aben Gold Corp.
SILDF5.09N/A
N/A
Sintokogio Ltd.
BNCDY40.70-0.71
-1.71%
Banca Mediolanum SPA

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with NRIX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-2.43%
NRIX - DNLI
58%
Loosely correlated
-0.74%
BEAM - DNLI
56%
Loosely correlated
-2.91%
OCUL - DNLI
54%
Loosely correlated
-2.48%
RGNX - DNLI
53%
Loosely correlated
-0.89%
ARWR - DNLI
52%
Loosely correlated
-1.39%
More

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
+0.48%
FBIOP - HLVX
81%
Closely correlated
+1.59%
BRIBF - HLVX
58%
Loosely correlated
N/A
DNLI - HLVX
49%
Loosely correlated
-2.43%
NTLA - HLVX
45%
Loosely correlated
-2.11%
IPSC - HLVX
44%
Loosely correlated
-1.68%
More